Letter

Nature 445, 324-327 (18 January 2007) | doi:10.1038/nature05395; Received 13 July 2006; Accepted 1 November 2006; Published online 20 December 2006

Toxoplasma co-opts host gene expression by injection of a polymorphic kinase homologue

J. P. J. Saeij1,3, S. Coller1,3, J. P. Boyle1, M. E. Jerome2, M. W. White2 and J. C. Boothroyd1

  1. Department of Microbiology and Immunology, Fairchild Building D305, 300 Pasteur Drive, Stanford University School of Medicine, Stanford, California 94305-5124, USA
  2. Department of Veterinary Molecular Biology, College of Agriculture, Montana State University, Bozeman, Montana 59717, USA
  3. These authors contributed equally to this work.

Correspondence to: J. C. Boothroyd1 Correspondence and requests for materials should be addressed to J.B. (Email: john.boothroyd@stanford.edu).

Toxoplasma gondii, an obligate intracellular parasite of the phylum Apicomplexa, can cause severe disease in humans with an immature or suppressed immune system. The outcome of Toxoplasma infection is highly dependent on the strain type, as are many of its in vitro growth properties1. Here we use genetic crosses between type II and III lines to show that strain-specific differences in the modulation of host cell transcription are mediated by a putative protein kinase, ROP16. Upon invasion by the parasite, this polymorphic protein is released from the apical organelles known as rhoptries and injected into the host cell, where it ultimately affects the activation of signal transducer and activator of transcription (STAT) signalling pathways and consequent downstream effects on a key host cytokine, interleukin (IL)-12. Our findings provide a new mechanism for how an intracellular eukaryotic pathogen can interact with its host and reveal important differences in how different Toxoplasma lineages have evolved to exploit this interaction.

Extra navigation

.

naturejobs

natureproducts


ADVERTISEMENT